PerkinElmer Sees 11 Percent Revenue Boost in Q3 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its revenues for the third quarter increased 11 percent, with strong growth coming from both its Human Health and Environmental Health divisions.

In the three months ended Oct. 3, the company posted revenues of $419.1 million, up from $377 million in the year-ago period. The results easily beat analysts' consensus estimate for revenues of $401.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.